Astrana Health (NASDAQ:ASTH) Stock Price Up 7.9% – Should You Buy?

Astrana Health, Inc. (NASDAQ:ASTH) shares rose 7.9% on Friday . The stock traded as high as $40.67 and last traded at $40.7880. 282,394 shares traded hands during trading, a decline of 49% from the average session volume of 554,100 shares. The stock had previously closed at $37.79.

Wall Street Analysts Forecast Growth

Several brokerages have commented on ASTH. Wall Street Zen cut shares of Astrana Health from a “buy” rating to a “hold” rating in a research note on Sunday. Robert W. Baird set a $45.00 target price on Astrana Health in a report on Friday, May 8th. Truist Financial boosted their target price on Astrana Health from $47.00 to $55.00 and gave the stock a “buy” rating in a research report on Monday, August 10th. Needham & Company LLC increased their price target on Astrana Health from $30.00 to $41.00 and gave the company a “buy” rating in a research note on Friday, May 8th. Finally, TD Cowen lifted their price objective on Astrana Health from $45.00 to $50.00 and gave the stock a “buy” rating in a research note on Tuesday, July 14th. Seven research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $49.43.

Astrana Health Stock Up 8.0%

The firm has a market capitalization of $2.27 billion, a PE ratio of 49.77 and a beta of 0.87. The business’s 50 day simple moving average is $41.34 and its 200 day simple moving average is $32.83. The company has a current ratio of 1.23, a quick ratio of 1.35 and a debt-to-equity ratio of 1.05.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in ASTH. Strs Ohio bought a new stake in Astrana Health during the fourth quarter worth approximately $40,000. Tower Research Capital LLC TRC lifted its stake in shares of Astrana Health by 323.3% in the 2nd quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock valued at $115,000 after purchasing an additional 3,517 shares during the last quarter. State of Wyoming bought a new stake in shares of Astrana Health in the 2nd quarter valued at approximately $132,000. Los Angeles Capital Management LLC bought a new stake in shares of Astrana Health in the 4th quarter valued at approximately $228,000. Finally, WINTON GROUP Ltd purchased a new position in shares of Astrana Health in the 2nd quarter worth approximately $233,000. Hedge funds and other institutional investors own 52.77% of the company’s stock.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.